...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Hypersensitivity with Inhalational Budesonide: An Under Recognised Entity
【24h】

Hypersensitivity with Inhalational Budesonide: An Under Recognised Entity

机译:吸入布地奈德超敏反应:认识不足的实体。

获取原文
           

摘要

Hypersensitivity reactions are commonly encountered with drugs such as beta lactams, sulphonamides, allopurinol etc., Corticosteroids are frequently employed in the treatment of drug induced allergic reactions. Therefore, it is highly unlikely that a corticosteroid itself may cause such a reaction as an adverse effect. We had encountered a rare case of hypersensitivity reaction with inhalational budesonide in an eight-year-old boy. The patient developed maculopapular rashes over the back, buttocks and legs accompanied with pruritus within four hours of administration of the first dose. The reaction subsided within two days on withdrawal of the drug and treatment with oral fexofenadine. Re-introduction of budesonide by the same route after a month resulted in appearance of similar reaction. Both the parents of the patient were known cases of allergic rhinitis suggesting allergic pre-disposition in the family. Causality analysis using WHO-UMC scale suggested certain association of this allergic reaction with inhaled budesonide.
机译:β-内酰胺,磺酰胺,别嘌醇等药物常会出现超敏反应。皮质类固醇常用于治疗药物引起的过敏反应。因此,皮质类固醇本身极不可能引起这种反应作为不良反应。我们在一个八岁男孩中遇到了罕见的吸入布地奈德超敏反应的情况。首次给药后四个小时内,患者背部,臀部和腿部出现斑丘疹,并伴有瘙痒。停药后两天内反应减弱,口服非索非那定治疗。一个月后通过相同途径重新引入布地奈德,导致出现类似反应。患者的父母都是已知的过敏性鼻炎病例,提示该家庭易患过敏。使用WHO-UMC量表的因果关系分析表明该过敏反应与吸入布地奈德有一定关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号